You just read:

ARCEDI Biotech Announces Publication Highlighting Success Of Cutting-Edge Cell-Based Noninvasive Prenatal Testing To Detect Aneuploidy And Subchromosomal Abnormalities In First Trimester Pregnancies

News provided by

ARCEDI Biotech ApS

17 Oct, 2017, 14:00 BST